---

$1.91

+0.0050 ( +0.26% ) 1.2M

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-12	Sale	-203810.00	Kassler-Taub Kenneth B.
2024-02-12	Sale	-204730.00	MAIN ALAN J
2024-02-12	Sale	-314320.00	WADE JEFFREY L
2024-02-12	Sale	-59660.00	Alexander Kristen
2024-02-12	Sale	-156950.00	McDermott Wendy
2023-11-17	Buy	90000.00	COATS LONNEL
2023-11-14	Buy	200000.00	Amouyal Philippe
2023-11-13	Buy	10000.00	COATS LONNEL
2023-10-12	Buy	508306.00	DEBBANE RAYMOND
2023-10-11	Sale	-248923.00	Garner Thomas